Aligned Genetics Inc (238120) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.058x

Based on the latest financial reports, Aligned Genetics Inc (238120) has a cash flow conversion efficiency ratio of -0.058x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.04 Billion ≈ $-1.38 Million USD) by net assets (₩35.50 Billion ≈ $24.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Aligned Genetics Inc to measure how many days the company can operate on defensive assets alone.

Aligned Genetics Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Aligned Genetics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aligned Genetics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aligned Genetics Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Western Alaska Minerals Corp V:WAM	-0.616x
Ferroamp Elektronik AB ST:FERRO	-0.003x
Cnova NV PA:CNV	-0.063x
SK Discovery Co Ltd KO:006125	0.001x
Asia Brands Bhd KLSE:7722	0.015x
Barfresh Food Group Inc NASDAQ:BRFH	-1.420x
Neofect Co.Ltd KQ:290660	-0.036x
Atlanta Poland SA WAR:ATP	0.164x

Annual Cash Flow Conversion Efficiency for Aligned Genetics Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Aligned Genetics Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Aligned Genetics Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩35.49 Billion ≈ $24.05 Million	₩3.07 Billion ≈ $2.08 Million	0.086x	-5.07%
2023-12-31	₩31.31 Billion ≈ $21.22 Million	₩2.85 Billion ≈ $1.93 Million	0.091x	+18.10%
2022-12-31	₩28.85 Billion ≈ $19.55 Million	₩2.22 Billion ≈ $1.51 Million	0.077x	+1429.28%
2021-12-31	₩26.99 Billion ≈ $18.29 Million	₩135.97 Million ≈ $92.14K	0.005x	+203.10%
2020-12-31	₩21.46 Billion ≈ $14.55 Million	₩35.67 Million ≈ $24.17K	0.002x	-94.71%
2019-12-31	₩20.97 Billion ≈ $14.21 Million	₩659.29 Million ≈ $446.79K	0.031x	+137.58%
2018-12-31	₩20.89 Billion ≈ $14.16 Million	₩-1.75 Billion ≈ $-1.18 Million	-0.084x	-116.08%
2017-12-31	₩22.64 Billion ≈ $15.34 Million	₩-876.75 Million ≈ $-594.16K	-0.039x	+17.86%
2016-12-31	₩24.18 Billion ≈ $16.39 Million	₩-1.14 Billion ≈ $-772.65K	-0.047x	+18.73%
2015-12-31	₩6.06 Billion ≈ $4.11 Million	₩-351.72 Million ≈ $-238.36K	-0.058x	--

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$32.15 Million

₩47.45 Billion KRW

Market Cap Rank

#23571 Global

#1597 in Korea

Share Price

₩3375.00

Change (1 day)

+1.66%

52-Week Range

₩3080.00 - ₩6050.00

All Time High

₩7875.00